Synaptic proteins linked to HIV-1 infection and immunoproteasome induction: proteomic analysis of human synaptosomes.
Infection of the central nervous system with human immunodeficiency virus type 1 (HIV-1) can produce morphological changes in the neocortical synaptodendritic arbor that are correlated with neurocognitive impairment. To determine whether HIV-1 infection influences the protein composition of human synapses, a proteomic study of isolated nerve endings was undertaken. Synaptosomes from frontal neocortex were isolated using isopyknic centrifugation from 19 human brain specimens. Purity and enrichment were assessed by measuring pre- and postsynaptic protein markers. Two-dimensional polyacrylamide gel electrophoresis and matrix-assisted laser desorption ionization time-of-flight mass spectrometry was used to screen for proteins differentially expressed in HIV/AIDS. The concentrations of 31 candidate protein spots were potentially abnormal in HIV-infected decedents with HIV encephalitis and/or increased expression of immunoproteasome subunits. Immunoblots showed that the concentration of some of them was related to HIV-1 infection of the brain and immunoproteasome (IPS) induction. Synapsin 1b and stathmin were inversely related to brain HIV-1 load; 14-3-3zeta and 14-4-4epsilon proteins were higher in subjects with HIV-1 loads. Perturbed synaptosome proteins were linked with IPS subunit composition, and 14-3-3zeta was histologically colocalized with IPS subunits in stained neocortical neurons. Proteomics illustrates that certain human proteins within the synaptic compartment are involved with changes in the synaptodendritic arbor and neurocognitive impairment in HIV-1-infected people.
Gelman
Benjamin B
BB
Department of Pathology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555, USA. bgelman@utmb.edu
Nguyen
Trung P
TP
D015526:AIDS Dementia Complex / Q000378:metabolism; D003072:Cognition Disorders / Q000150:complications / Q000378:metabolism; D005625:Frontal Lobe / Q000378:metabolism / Q000821:virology; D015967:Gene Expression Regulation, Viral; D015658:HIV Infections / Q000150:complications / Q000378:metabolism*; D015497:HIV-1; D006801:Humans; D009419:Nerve Tissue Proteins / Q000378:metabolism*; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism; D040901:Proteomics / Q000379:methods*; D013574:Synaptosomes / Q000378:metabolism* / Q000821:virology
D009419:Nerve Tissue Proteins; D046988:Proteasome Endopeptidase Complex
Ann Neurol. 2003 Jul;54(1):135
12838532
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9241-6
15944226
Clin Chim Acta. 2001 Oct;312(1-2):97-105
11580914
J Clin Microbiol. 2003 Oct;41(10):4531-6
14532178
Ann Neurol. 1994 Oct;36(4):673-6
7944304
Hum Mol Genet. 1996 Apr;5(4):481-7
8845840
J Neurosci Res. 2007 Sep;85(12):2648-56
17455288
Ann Neurol. 1997 Jul;42(1):34-40
9225683
Biochem J. 2001 Oct 1;359(Pt 1):55-64
11563969
Neurology. 2001 Jan 23;56(2):257-60
11160967
FEBS Lett. 1987 Jul 13;219(1):79-82
2885229
Ann Neurol. 2000 Sep;48(3):395-8
10976650
J Neurochem. 2001 May;77(4):1097-107
11359875
J Neurosci. 2004 Dec 15;24(50):11368-80
15601943
J Neurobiol. 2004 Jan;58(1):60-9
14598370
Curr Opin Neurobiol. 2006 Feb;16(1):90-4
16427269
Acta Neuropathol. 2004 Oct;108(4):279-86
15235803
Plant Mol Biol. 2002 Dec;50(6):1041-51
12516871
Prog Neurobiol. 2004 Aug;73(5):311-57
15312912
J Neurochem. 2003 Jan;84(1):23-34
12485398
J Neurochem. 2006 Mar;96(6):1560-71
16464236
Neuron. 1999 Apr;22(4):809-18
10230800
Neuron. 2006 Oct 19;52(2):239-45
17046687
Acta Neuropathol. 2004 Mar;107(3):209-15
14673601
Curr Pharm Biotechnol. 2006 Jun;7(3):217-23
16789906
J Neurochem. 2002 Apr;81(2):292-300
12064476
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2880-5
16481620
Am J Pathol. 2002 Feb;160(2):469-80
11839567
Sex Transm Infect. 2000 Oct;76(5):408
11141866
Neuropathol Appl Neurobiol. 2001 Aug;27(4):326-35
11532163
Neurology. 2000 Aug 22;55(4):514-6
10953182
J Neurochem. 2009 Jan;108(1):260-72
19012754
J Biol Chem. 2000 Aug 18;275(33):25247-54
10840038
J Neuropathol Exp Neurol. 2002 Mar;61(3):245-53
11895039
Neurosci Lett. 2007 Jul 11;422(2):114-8
17602838
Nature. 2001 Apr 19;410(6831):988-94
11309629
J Neuroimmunol. 2004 Dec;157(1-2):3-10
15579274
Curr Opin Neurobiol. 2005 Oct;15(5):536-41
16150592
Ann Neurol. 1995 Nov;38(5):755-62
7486867
J Neuroimmunol. 2004 Dec;157(1-2):111-9
15579287
Nature. 1995 Jun 8;375(6531):488-93
7777057
J Pharmacol Exp Ther. 2001 Feb;296(2):442-9
11160629
Neuron. 2005 Sep 1;47(5):629-32
16129392
J Neurovirol. 2004 Apr;10(2):98-108
15204928
J Anat. 1962 Jan;96:79-88
13901297
Nat Neurosci. 2001 Dec;4(12):1187-93
11685225
Neurosci Lett. 2001 Feb 9;298(3):191-4
11165439
Nat Rev Neurosci. 2003 Sep;4(9):752-62
12951567
J Physiol. 2002 Nov 15;545(1):13-26
12433946
J Neurol Sci. 2000 Apr 15;175(2):81-90
10831767
J Neurosci. 2008 Oct 8;28(41):10245-56
18842884
J Neuropathol Exp Neurol. 2005 Mar;64(3):202-8
15804051
Brain Res. 1981 Dec 7;226(1-2):107-18
7296283
Acta Neuropathol. 2003 Mar;105(3):296-302
12557018
Ann Neurol. 1997 Dec;42(6):963-72
9403489
Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):21-6
16373512